Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uffe Ravnskov

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Mbio|September 18, 2014
Biofilms, lipoprotein aggregates, homocysteine, and arterial plaque ruptureUffe Ravnskov, Kilmer S McCully
Expert Review of Clinical Pharmacology|February 13, 2015
How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular diseaseDavid M Diamond, Uffe Ravnskov
JAMA|July 9, 2004
Aggressive lipid-lowering therapy and regression of coronary atheromaUffe Ravnskov, Morley C Sutter
The American Journal of the Medical Sciences|April 13, 2012
Infections may be causal in the pathogenesis of atherosclerosisUffe Ravnskov, Kilmer S McCully
Expert Review of Clinical Pharmacology|October 27, 2015
Additional commentary on deception in statin researchDavid M Diamond, Uffe Ravnskov
Journal of Atherosclerosis and Thrombosis|July 13, 2012
How macrophages are converted to foam cellsUffe Ravnskov, Kilmer S McCully
Circulation|April 30, 2019
Letter by Ravnskov et al Regarding Article, "Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longitudinal Study"Uffe Ravnskov, Harumi Okuyama, Sherif Sultan
BMJ (Clinical Research Ed.)|November 2, 2017
Serious bias in 20 year follow-up study of statin trialUffe Ravnskov, Harumi Okuyama, Sherif Sultan
JAMA Internal Medicine|December 6, 2016
Association of Specific Dietary Fats With MortalityUffe Ravnskov, Harumi Okuyama, Zoë Harcombe
The New England Journal of Medicine|July 9, 2005
Intensive lipid lowering with atorvastatin in coronary diseaseUffe Ravnskov, Paul J Rosch, Morley C Sutter
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Mbio|September 18, 2014
Biofilms, lipoprotein aggregates, homocysteine, and arterial plaque ruptureUffe Ravnskov, Kilmer S McCully
Expert Review of Clinical Pharmacology|February 13, 2015
How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular diseaseDavid M Diamond, Uffe Ravnskov
JAMA|July 9, 2004
Aggressive lipid-lowering therapy and regression of coronary atheromaUffe Ravnskov, Morley C Sutter
The American Journal of the Medical Sciences|April 13, 2012
Infections may be causal in the pathogenesis of atherosclerosisUffe Ravnskov, Kilmer S McCully
Expert Review of Clinical Pharmacology|October 27, 2015
Additional commentary on deception in statin researchDavid M Diamond, Uffe Ravnskov
Journal of Atherosclerosis and Thrombosis|July 13, 2012
How macrophages are converted to foam cellsUffe Ravnskov, Kilmer S McCully
Circulation|April 30, 2019
Letter by Ravnskov et al Regarding Article, "Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular Disease: Results From the Cooper Center Longitudinal Study"Uffe Ravnskov, Harumi Okuyama, Sherif Sultan
BMJ (Clinical Research Ed.)|November 2, 2017
Serious bias in 20 year follow-up study of statin trialUffe Ravnskov, Harumi Okuyama, Sherif Sultan
JAMA Internal Medicine|December 6, 2016
Association of Specific Dietary Fats With MortalityUffe Ravnskov, Harumi Okuyama, Zoë Harcombe
The New England Journal of Medicine|July 9, 2005
Intensive lipid lowering with atorvastatin in coronary diseaseUffe Ravnskov, Paul J Rosch, Morley C Sutter
Pageof 7